Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy

Journal of Pain

Volumn 16, Issue 7, 2015, Pages 616-627

  Wallace, Mark S ^a   Marcotte, Thomas D ^b   Umlauf, Anya ^b   Gouaux, Ben ^b   Atkinson, Joseph H ^b,c  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cannabis; clinical trial; Diabetic peripheral neuropathy

Indexed keywords

ANTIDEPRESSANT AGENT; CANNABIS; INSULIN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TETRAHYDROCANNABINOL; ANALGESIC AGENT; DRONABINOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC PERIPHERAL NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EUPHORIA; EVOKED RESPONSE; FEMALE; FOAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LOW DRUG DOSE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PACED AUDITORY SERIAL ADDITION TEST; PAIN; PAIN ASSESSMENT; PAIN INTENSITY; PERIPHERAL NEUROPATHY; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; TREATMENT DURATION; AGED; ANALYSIS OF VARIANCE; DEPRESSION; DIABETIC NEUROPATHIES; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; PAIN MEASUREMENT; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AGED; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; COGNITION; CROSS-OVER STUDIES; DEPRESSION; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 84937638400     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2015.03.008     Document Type: Article

References (51)

1. D.I. Abrams, C.A. Jay, S.B. Shade, H. Vizoso, H. Reda, S. Press, M.E. Kelly, M.C. Rowbotham, and K.L. Petersen Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial Neurology 68 2007 515 521
2. D.I. Abrams, H.P. Vizoso, S.B. Shade, C. Jay, M.E. Kelly, and N.L. Benowitz Vaporization as a smokeless cannabis delivery system: A pilot study Clin Pharmacol Ther 82 2007 572 578
3. A.J. Boulton, R.A. Malik, J.C. Arezzo, and J.M. Sosenko Diabetic somatic neuropathies Diabetes Care 27 2004 1458 1486
4. D. Bridges, K. Ahmad, and A.S. Rice The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Br J Pharmacol 133 2001 586 594
5. W.C. Clark, M.N. Janal, P. Zeidenberg, and G.G. Nahas Effects of moderate and high doses of marihuana on thermal pain: A sensory decision theory analysis J Clin Pharmacol 21 1981 299S 310S
6. M. daCosta DiBonaventura, J.C. Cappelleri, and A.V. Joshi A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost Pain Med 12 2011 118 126
7. E. De Meijer The breeding of cannabis cultivars for pharmaceutical end uses G.W. Guy, B.A. Whittle, P. Robson, Medicinal Uses of Cannabis and Cannabinoids 2004 Pharmaceutical Press London 55 70
8. J. De Vry 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects J Pharmacol Exp Ther 310 2004 3221 3233
9. A. Dogrul, H. Gul, O. Yildiz, F. Bilgin, and M.E. Guzeldemir Cannabinoids block tactile allodynia in diabetic mice without attenuation of its antinociceptive effect Neurosci Lett 368 2004 82 86
10. K.J.A. Dozois, K.S. Dobson, and J.L. Ahnberg A psychometric evaluation of the Beck Depression Inventory-II Psychol Assess 10 1998 83 89
11. R.H. Dworkin, D.C. Malone, C.J. Panarites, E.P. Armstrong, and S.V. Pham Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs J Pain 11 2010 360 368
12. R.H. Dworkin, A.B. O'Connor, J. Audette, R. Baron, G.K. Gourlay, M.L. Haanpaa, J.L. Kent, E.J. Krane, A.A. Lebel, R.M. Levy, S.C. Mackey, J. Mayer, C. Miaskowski, S.N. Raja, A.S. Rice, K.E. Schmader, B. Stacey, S. Stanos, R.D. Treede, D.C. Turk, G.A. Walco, and C.D. Wells Recommendations for the pharmacological management of neuropathic pain: An overview and literature update Mayo Clin Proc 85 3 suppl 2010 S3 S14
13. P.J. Dyck, K.M. Kratz, J.L. Karnes, W.J. Litchy, R. Klein, J.M. Pach, D.M. Wilson, P.C. O'Brien, L.J. Melton 3rd, and F.J. Service The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study Neurology 43 1993 817 824
14. R.J. Ellis, W. Toperoff, F. Vaida, G. van den Brande, J. Gonzales, B. Gouaux, H. Bentley, and J.H. Atkinson Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial Neuropsychopharmacology 34 2009 672 680
15. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
16. V.D. Federov, F. Mannino, and R. Zhang Consequences of dichotomization Pharm Stat 8 2009 50 61
17. D. Firth Bias reduction of maximum likelihood estimates Biometrika 80 1993 27 38
18. J.L. Fleiss The Design and Analysis of Clinical Experiments 1999 John Wiley and Sons, Inc New York, NY
19. R.W. Foltin, M.W. Fischman, and M.F. Byrne Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory Appetite 11 1988 1 14
20. R. Freeman, E. Durso-Decruz, and B. Emir Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: Findings from seven randomized, controlled trials across a range of doses Diabetes Care 31 2008 1448 1454
21. B.S. Galer, A. Gianas, and M.P. Jensen Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life Diabetes Res Clin Pract 47 2000 123 128
22. Y. Gaoni, and R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1964 1646 1647
23. A. Gordois, P. Scuffham, A. Shearer, A. Oglesby, and J.A. Tobian The health care costs of diabetic peripheral neuropathy in the US Diabetes Care 26 2003 1790 1795
24. L. Grlic A comparative study on some chemical and biological characteristics of various samples of cannabis resin Bull Narc 3 1962 37 46
25. D.M. Gronwall Paced auditory serial-addition task: A measure of recovery from concussion Percept Mot Skills 44 1977 367 373
26. F.A. Grotenhermen Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 42 2003 327 360
27. K. Hayakawa, K. Mishima, M. Hazekawa, K. Sano, K. Irie, K. Orito, T. Egawa, Y. Kitamura, N. Uchida, R. Nishimura, N. Egashira, K. Iwasaki, and M. Fujiwara Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism Brain Res 1188 2008 157 164
28. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain. A quantitative in vitro autoradiographic study J Neurosci 11 1991 563 583
29. A.G. Hohmann, and M. Herkenham Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study Neuroscience 90 1999 923 931
30. J.R. Johnson, M. Burnell-Nugent, D. Lossigno, E.D. Ganae-Motan, and R. Potts Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain J Pain Symptom Manage 182 2010 E694 E701
31. H. Lesser, U. Sharma, L. LaMoreaux, and R.M. Poole Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial Neurology 63 2004 2104 2110
32. G. Lim, B. Sung, R.R. Ji, and J. Mao Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats Pain 105 2003 275 283
33. G. Marsicano, and B. Lutz Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 1999 4213 4225
34. W.J. Martin, S.L. Patrick, P.O. Coffin, K. Tsou, and J.M. Walker An examination of the central sites of action of cannabinoid-induced antinociception in the rat Life Sci 56 1995 2103 2109
35. A. Moghtaderi, A. Bakhshipour, and H. Rashidi Validation of Michigan Neuropathy Screening Instrument for diabetic peripheral neuropathy Clin Neurol Neurosurg 108 2006 477 481
36. R.K. Portenoy, E.D. Ganae-Motan, S. Allende, R. Yanagihara, L. Shaiova, S. Weinstein, R. McQuade, S. Wright, and M.T. Fallon Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A randomized, placebo-controlled, graded-dose trial J Pain 13 2012 438 449
37. S. Quilici, J. Chancellor, M. Lothgren, D. Simon, G. Said, T.K. Le, A. Garcia-Cebrian, and B. Monz Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain BMC Neurol 9 2009 6
38. L.E. Reeves, D.M. Anglin, R.G. Heimberg, L.E. Gibson, A.M. Fineberg, S.D. Maxwell, C.M. Kerns, and L.M. Ellman Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms Psychiatry Res 218 2014 180 186
39. R.M. Reitan, and L.A. Davidson Neuropsychology: Current Status and Application 1974 Winston and Sons Washington, DC
40. L.N. Robbins National Institute of Mental Health Diagnostic Interview Schedule Arch Gen Psychiatry 140 1981 201 206
41. S. Senn Statistical Issues in Drug Development 2007 John Wiley & Sons Ltd West Sussex, England
42. A. Siegling, H.A. Hofmann, D. Denzer, F. Mauler, and J. De Vry Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic pain Eur J Pharmacol 415 2001 R5 R7
43. S.M. Snapinn, and Q. Jiang Responder analyses and the assessment of a clinically relevant treatment effect Trials 8 2007 31
44. S. Tesfaye Impact of painful diabetic polyneuropathy on patients E.F. Lawson, M. Backonja, Painful Diabetic Polyneuropathy: A Comprehensive Guide for Clinicians 2013 Springer Science New York 155 166
45. K. Tsou, S. Brown, M.C. Sanudo-Pena, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 1998 393 411
46. A. Ulugol, H.C. Karadag, Y. Ipci, M. Tamer, and I. Dokmeci The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats Neurosci Lett 371 2004 167 170
47. M. Wallace, G. Schulteis, J.H. Atkinson, T. Wolfson, D. Lazzaretto, H. Bentley, B. Gouaux, and I. Abramson Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers Anesthesiology 107 2007 785 796
48. M.A. Ware, T. Wang, S. Shapiro, A. Robinson, T. Ducruet, T. Huynh, A. Gamsa, G.J. Bennett, and J.P. Collet Smoked cannabis for chronic neuropathic pain: A randomized controlled trial CMAJ 182 2010 E694 E701
49. B. Wilsey, T. Marcotte, R. Deutsch, B. Gouaux, S. Sakai, and H. Donaghe Low-dose vaporized cannabis significantly improves neuropathic pain J Pain 14 2013 136 148
50. B. Wilsey, T. Marcotte, A. Tsodikov, J. Millman, H. Bentley, B. Gouaux, and S. Fishman A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain J Pain 9 2008 506 521
51. J. Zhang, C. Hoffert, H.K. Vu, T. Groblewski, S. Ahmad, and D. O'Donnell Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models Eur J Neurosci 17 2003 2750 2754